Long-term effect of corticosteroid treatment during acute COVID-19 infection on pulmonary function test results.

ABSTRACT:

Background

The outbreak of the novel coronavirus 19 has led to unprecedented clinical challenges globally. Various therapeutic and pharmacologic interventions have been proposed, yet evidence of their long-term efficacy remains limited. Corticosteroids (CS) have shown efficacy in the sub-acute phase of the pandemic. This study aims to evaluate the long-term effects on pulmonary function tests (PFTs) in patients treated with CS during acute coronavirus disease 2019 (COVID-19) infection.

Methods

A retrospective study was conducted from February 2020 to March 2021. Clinical and demographic data were extracted from electronic medical records of patients attending the post-COVID outpatient clinic at the Pulmonary Institute of Soroka University Medical Center. A multivariate linea

SUBMITTER: Boehm Cohen L 

PROVIDER: S-EPMC11388253 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature